Consainsights logo

Next Generation Sequencing Informatics Market Size, Share, Industry Trends and Forecast to 2033

This report covers the analysis of the Next Generation Sequencing Informatics market from 2023 to 2033, presenting insights into market size, trends, regional dynamics, and key players influencing the industry.

Metric Value
Study Period 2023 - 2033
2023 Market Size $5.60 Billion
CAGR (2023-2033) 9.2%
2033 Market Size $13.91 Billion
Top Companies Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc.
Last Modified Date 15 Nov 2024

Next Generation Sequencing Informatics Market Report (2023 - 2033)

Next Generation Sequencing Informatics Market Overview

The NGS informatics industry is marked by rapid technological evolution and a competitive landscape. Organizations are investing in R&D to enhance the capabilities of informatics software, aiming to improve data management and analysis methodologies. Regulatory considerations and data privacy issues remain critical as the industry navigates expanding applications of genomic data. Collaboration between academic institutions and biotechnology companies is fostering innovation, while the increasing volume of sequencing data necessitates robust informatics solutions capable of supporting complex analyses. The push towards cloud-based solutions also signifies a shift towards more scalable and cost-effective data processing options.

What is the Market Size & CAGR of Next Generation Sequencing Informatics market in 2023?

The Next Generation Sequencing Informatics market size in 2023 is projected to be approximately USD 4 billion, with an anticipated compound annual growth rate (CAGR) of 10% from 2023 to 2033. This growth reflects a surge in demand for genomic sequencing in various applications, from oncology and genomics research to pharmacogenomics and agriculture. As healthcare globally moves towards personalized medicine, NGS informatics is becoming indispensable, further catalyzing market expansion.

Next Generation Sequencing Informatics Industry Analysis

The NGS informatics industry is marked by rapid technological evolution and a competitive landscape. Organizations are investing in R&D to enhance the capabilities of informatics software, aiming to improve data management and analysis methodologies. Regulatory considerations and data privacy issues remain critical as the industry navigates expanding applications of genomic data. Collaboration between academic institutions and biotechnology companies is fostering innovation, while the increasing volume of sequencing data necessitates robust informatics solutions capable of supporting complex analyses. The push towards cloud-based solutions also signifies a shift towards more scalable and cost-effective data processing options.

Next Generation Sequencing Informatics Market Segmentation and Scope

The NGS informatics market can be segmented into various categories, including technology, application, end-user, and software type. Key segments include: 1. **By Technology**: Focused on platforms used for sequencing such as sequencing as a service and data analysis tools. 2. **By Application**: Encompassing oncology, genomics, microbiology, and pharmacogenomics, among others. 3. **By End-User**: Targeting academic institutions, biotechnology and pharmaceutical companies, healthcare providers, and research organizations. 4. **By Software Type**: Divided into cloud-based solutions and on-premises software. Each segment plays a pivotal role in shaping the overall market landscape and caters to specific user needs, driving demand for specialized informatics solutions.

Request a custom research report for industry.

Next Generation Sequencing Informatics Market Analysis Report by Region

Europe Next Generation Sequencing Informatics Market Report:

Europe's market is projected to expand from USD 1.44 billion in 2023 to USD 3.58 billion by 2033, with strong contributions from countries like Germany and the UK, where substantial genomic research initiatives are underway.

Asia Pacific Next Generation Sequencing Informatics Market Report:

The Asia Pacific region is expected to grow from USD 1.22 billion in 2023 to USD 3.02 billion by 2033, driven by increasing investments in genomics research and advancements in healthcare technology. Countries like China and India are emerging as major players in the NGS informatics landscape.

North America Next Generation Sequencing Informatics Market Report:

North America dominates the NGS informatics market, with a size of USD 1.80 billion in 2023, expected to reach USD 4.48 billion by 2033. The region benefits from a robust healthcare infrastructure, high research spending, and leading biotech and pharmaceutical companies.

South America Next Generation Sequencing Informatics Market Report:

The South American market is projected to scale from USD 0.47 billion in 2023 to USD 1.17 billion by 2033, supported by a growing focus on personalized medicine and governmental initiatives to boost biotechnology sector performance.

Middle East & Africa Next Generation Sequencing Informatics Market Report:

The Middle East and Africa region's market is anticipated to grow from USD 0.67 billion in 2023 to USD 1.67 billion by 2033, driven by increased healthcare spending and collaborations between private and public sectors.

Request a custom research report for industry.

Next Generation Sequencing Informatics Market Analysis By Technology

Global Next Generation Sequencing Informatics Market, By Technology Market Analysis (2023 - 2033)

The technology segment features notable growth in cloud-based solutions, with its market size projected to rise from USD 4.91 billion in 2023 to USD 12.20 billion by 2033, reflecting a growing preference for scalable data handling. On-premises software represents a smaller but essential component, expected to grow from USD 0.69 billion to USD 1.71 billion over the same period.

Next Generation Sequencing Informatics Market Analysis By Application

Global Next Generation Sequencing Informatics Market, By Application Market Analysis (2023 - 2033)

In the application segment, oncology leads the market with a size of USD 2.48 billion in 2023, escalating to USD 6.15 billion by 2033. Other key applications include genomics and microbiology, all of which are leveraging NGS for better treatment outcomes and research advancements.

Next Generation Sequencing Informatics Market Analysis By End User

Global Next Generation Sequencing Informatics Market, By End-User Market Analysis (2023 - 2033)

Key end-users of NGS informatics include academic institutions, biotechnology companies, pharmaceutical companies, healthcare providers, and research organizations. Academic institutions are critical, holding a 44.2% market share in 2023 and foreseen to maintain robustness into 2033.

Next Generation Sequencing Informatics Market Analysis By Software Type

Global Next Generation Sequencing Informatics Market, By Software Type Market Analysis (2023 - 2033)

Cloud-based software takes a significant share of the NGS informatics market at 87.7% in 2023 and is expected to see significant growth as organizations favor flexible, cost-effective solutions.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Next Generation Sequencing Informatics Industry

Illumina, Inc.:

A leading developer of life science tools and integrated biotechnology solutions, primarily focused on sequencing and array-based technologies.

Thermo Fisher Scientific Inc.:

Provides a range of bioinformatics solutions alongside its comprehensive suite of genetic and molecular biology tools aimed at accelerating NGS workflows.

Agilent Technologies, Inc.:

Offers advanced instrumentation and software for genomics applications, enhancing genomics research and diagnostics capabilities.

Bio-Rad Laboratories, Inc.:

Delivers innovative solutions for the life science and clinical diagnostics markets with a strong focus on genomics and NGS informatics.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs